Literature DB >> 3809591

Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.

B Maciejewski, J M Taylor, H R Withers.   

Abstract

In a group of 155 cases with squamous cell carcinoma of the supraglottic larynx (T3-4N0M0), with 3-year local control after radiotherapy, 21 late complications were noted. Using two different methods, an alpha/beta value of 3.8 Gy was calculated. A strong correlation between the risk of late effect in the larynx and size of dose per fraction was found; there was no influence of overall treatment time.

Entities:  

Mesh：

Year:  1986        PMID： 3809591     DOI： 10.1016/s0167-8140(86)80061-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

1.  Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Authors:  J C Flickinger; A H Epstein; S Iwatsuki; B I Carr; T E Starzl
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

2.  Hypofractionated Accelerated Chemo-radiotherapy (Chemo-HypoAR) With Cisplatin and Liposomal Doxorubicin for the Treatment of Patients With Uterine Sarcomas.

Authors:  Spyros Domoxoudis; Ioannis M Koukourakis; Axiotis G Giakzidis; Michael I Koukourakis
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

3.  Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.

Authors:  G van Tienhoven; B J Mijnheer; H Bartelink; D G González
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 4.  Partial breast irradiation versus whole breast radiotherapy for early breast cancer.

Authors:  Brigid E Hickey; Margot Lehman
Journal:  Cochrane Database Syst Rev       Date:  2021-08-30

5.  Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients.

Authors:  Christos Nanos; Vasilios Souftas; Athanasios Zissimopoulos; Michael I Koukourakis
Journal:  Radiat Oncol J       Date:  2022-06-20

Review 6.  Partial breast irradiation for early breast cancer.

Authors:  Brigid E Hickey; Margot Lehman; Daniel P Francis; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

7.  Late effects of radiotherapy on hearing.

Authors:  L J Schot; F J Hilgers; R B Keus; P F Schouwenburg; W A Dreschler
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

8.  Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens.

Authors:  H Sudahar; P G G Kurup; V Murali; P Mahadev; J Velmurugan
Journal:  J Med Phys       Date:  2012-04

Review 9.  Fraction size in radiation therapy for breast conservation in early breast cancer.

Authors:  Brigid E Hickey; Melissa L James; Margot Lehman; Phil N Hider; Mark Jeffery; Daniel P Francis; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

10.  Concurrent hypofractionated radiotherapy and 5-Fluorouracil for advanced sarcomas of the bone.

Authors:  C Zambatis; J Skarlatos; M Koukourakis; L Kosma; A Giatromanolaki; K Beroukas; D Yannakakis
Journal:  Sarcoma       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.